Other Assets, Noncurrent in USD of AVADEL PHARMACEUTICALS PLC from Q4 2014 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of noncurrent assets classified as other.
Summary
AVADEL PHARMACEUTICALS PLC quarterly Other Assets, Noncurrent history and change rate from Q4 2014 to Q3 2025.
  • AVADEL PHARMACEUTICALS PLC Other Assets, Noncurrent for the quarter ending 30 Sep 2025 was $7.38M, a 37.3% decline year-over-year.
Other Assets, Noncurrent, Quarterly (USD)
Other Assets, Noncurrent, YoY Quarterly Change (%)

AVADEL PHARMACEUTICALS PLC Quarterly Other Assets, Noncurrent (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $7.38M -$4.39M -37.3% 30 Sep 2025 10-Q 04 Nov 2025
Q2 2025 $8.02M -$3.99M -33.2% 30 Jun 2025 10-Q 07 Aug 2025
Q1 2025 $8.65M -$3.12M -26.5% 31 Mar 2025 10-Q 07 May 2025
Q4 2024 $11M +$553K +5.28% 31 Dec 2024 10-Q 04 Nov 2025
Q3 2024 $11.8M +$1.61M +15.9% 30 Sep 2024 10-Q 12 Nov 2024
Q2 2024 $12M +$1.48M +14% 30 Jun 2024 10-Q 08 Aug 2024
Q1 2024 $11.8M +$837K +7.66% 31 Mar 2024 10-Q 08 May 2024
Q4 2023 $10.5M -$838K -7.4% 31 Dec 2023 10-K 03 Mar 2025
Q3 2023 $10.1M -$1.57M -13.4% 30 Sep 2023 10-Q 08 Nov 2023
Q2 2023 $10.5M -$1.23M -10.5% 30 Jun 2023 10-Q 09 Aug 2023
Q1 2023 $10.9M -$28.7M -72.4% 31 Mar 2023 10-Q 04 May 2023
Q4 2022 $11.3M -$22.5M -66.5% 31 Dec 2022 10-K 29 Feb 2024
Q3 2022 $11.7M -$26.4M -69.2% 30 Sep 2022 10-Q 09 Nov 2022
Q2 2022 $11.8M -$19.7M -62.6% 30 Jun 2022 10-Q 09 Aug 2022
Q1 2022 $39.6M +$11.9M +43% 31 Mar 2022 10-Q 09 May 2022
Q4 2021 $33.8M +$8.84M +35.4% 31 Dec 2021 10-K 29 Mar 2023
Q3 2021 $38.1M +$15.8M +71.1% 30 Sep 2021 10-Q 08 Nov 2021
Q2 2021 $31.5M -$6.12M -16.3% 30 Jun 2021 10-Q 09 Aug 2021
Q1 2021 $27.7M -$19.8M -41.7% 31 Mar 2021 10-Q 10 May 2021
Q4 2020 $24.9M -$14.3M -36.5% 31 Dec 2020 10-K 16 Mar 2022
Q3 2020 $22.3M -$12.7M -36.3% 30 Sep 2020 10-Q 09 Nov 2020
Q2 2020 $37.6M +$3.04M +8.8% 30 Jun 2020 10-Q 10 Aug 2020
Q1 2020 $47.5M +$11.4M +31.6% 31 Mar 2020 10-Q 11 May 2020
Q4 2019 $39.3M +$3.13M +8.65% 31 Dec 2019 10-K 09 Mar 2021
Q3 2019 $34.9M +$10.1M +40.6% 30 Sep 2019 10-Q 12 Nov 2019
Q2 2019 $34.6M +$12.3M +55.4% 30 Jun 2019 10-Q 09 Aug 2019
Q1 2019 $36.1M +$15.9M +78.5% 31 Mar 2019 10-Q 08 May 2019
Q4 2018 $36.1M +$25.9M +253% 31 Dec 2018 10-K 16 Mar 2020
Q3 2018 $24.8M +$15.8M +175% 30 Sep 2018 10-Q 05 Nov 2018
Q2 2018 $22.2M +$14M +170% 30 Jun 2018 10-Q 07 Aug 2018
Q1 2018 $20.2M +$12.7M +169% 31 Mar 2018 10-Q 04 May 2018
Q4 2017 $10.2M +$2.72M +36.1% 31 Dec 2017 10-K 15 Mar 2019
Q3 2017 $9.02M +$2.2M +32.3% 30 Sep 2017 10-Q 09 Nov 2017
Q2 2017 $8.24M +$2.58M +45.6% 30 Jun 2017 10-Q 09 Aug 2017
Q1 2017 $7.53M +$7.52M 31 Mar 2017 10-Q 10 May 2017
Q4 2016 $7.53M +$7.36M +4410% 31 Dec 2016 10-K 16 Mar 2018
Q3 2016 $6.82M 30 Sep 2016 10-Q 14 Nov 2016
Q2 2016 $5.66M 30 Jun 2016 10-Q 15 Aug 2016
Q1 2016 $16K* 31 Mar 2016 10-Q 10 May 2016
Q4 2015 $167K +$42K +33.6% 31 Dec 2015 10-K 28 Mar 2017
Q4 2014 $125K 31 Dec 2014 10-K 15 Mar 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.